ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.97
      0.35%
      Bitcoin
      94,909.77
      -0.21%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Sana Biotechnology Inc (SANA) Quote

      Sana Biotechnology Inc

      Sana Biotechnology Inc (SANA)

      NASDAQ
      1.65
      0.05
      (3.12%)
      Closed December 23 4:00PM
      Delayed by 15 minutes
      1.72
      0.07
      (4.24%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.72
      Bid
      1.62
      Ask
      1.73
      Volume
      3,201,202
      1.55 Day's Range 1.72
      1.55 52 Week Range 12.00
      Market Cap
      384.022M
      Previous Close
      1.60
      Open
      1.60
      Last Trade
      1
      @
      1.72
      Last Trade Time
      Financial Volume
      $ 5,205,822
      VWAP
      1.6262
      Average Volume (3m)
      1,594,046
      Shares Outstanding
      223,268,889
      Dividend Yield
      -
      PE Ratio
      -1.32
      Earnings Per Share (EPS)
      -1.27
      Revenue
      -
      Net Profit
      -283.26M

      About Sana Biotechnology Inc

      Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring tec... Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.sana.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Sana Biotechnology Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SANA. The last closing price for Sana Biotechnology was $1.60. Over the last year, Sana Biotechnology shares have traded in a share price range of $ 1.55 to $ 12.00.

      Sana Biotechnology currently has 223,268,889 shares outstanding. The market capitalization of Sana Biotechnology is $357.23 million. Sana Biotechnology has a price to earnings ratio (PE ratio) of -1.32.

      Ask ADVFN Intelligence (AI)

      SANA Latest News

      More News

      Form 144 - Report of proposed sale of securities

      December 16 2024
      Edgar (US Regulatory)

      Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus

      Fast Track designation is designed to expedite clinical development and regulatory review timelines Enrolling patients in the GLEAM trial for SC291 in B-cell mediated autoimmune diseases...

      December 02 2024
      GlobeNewswire Inc.

      Form 144 - Report of proposed sale of securities

      November 26 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 25 2024
      Edgar (US Regulatory)

      Sana Biotechnology to Present at December 2024 Investor Conferences

      SEATTLE, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will...

      November 25 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 08 2024
      Edgar (US Regulatory)

      Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates

      Continue to advance hypoimmune technology in three trials across five indications in type 1 diabetes, B-cell mediated autoimmune diseases, and oncology Enrolling patients in the...

      November 08 2024
      GlobeNewswire Inc.

      Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025

      Prioritize clinical and preclinical development on type 1 diabetes (UP421 and SC451), B-cell mediated autoimmune diseases (SC291), refractory B-cell malignancies (SC262), and the fusogen platform...

      November 04 2024
      GlobeNewswire Inc.

      Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

      Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence PR Newswire CAMBRIDGE, Masss. and LONDON, Oct...

      October 23 2024
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.17-8.994708994711.892.041.5529296711.79766548CS
      4-0.68-28.33333333332.43.071.5520503472.22188049CS
      12-2.49-59.14489311164.214.4451.5515940462.92544664CS
      26-3.96-69.71830985925.687.41.5516603754.2734225CS
      52-2.51-59.33806146574.23121.5521076386.20146624CS
      156-14.75-89.556769884616.4716.791.5515255735.99199362CS
      260-36.18-95.461741424837.944.61.5513299648.01569945CS

      SANA - Frequently Asked Questions (FAQ)

      What is the current Sana Biotechnology share price?
      The current share price of Sana Biotechnology is $ 1.72
      How many Sana Biotechnology shares are in issue?
      Sana Biotechnology has 223,268,889 shares in issue
      What is the market cap of Sana Biotechnology?
      The market capitalisation of Sana Biotechnology is USD 357.23M
      What is the 1 year trading range for Sana Biotechnology share price?
      Sana Biotechnology has traded in the range of $ 1.55 to $ 12.00 during the past year
      What is the PE ratio of Sana Biotechnology?
      The price to earnings ratio of Sana Biotechnology is -1.32
      What is the reporting currency for Sana Biotechnology?
      Sana Biotechnology reports financial results in USD
      What is the latest annual profit for Sana Biotechnology?
      The latest annual profit of Sana Biotechnology is USD -283.26M
      What is the registered address of Sana Biotechnology?
      The registered address for Sana Biotechnology is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Sana Biotechnology website address?
      The website address for Sana Biotechnology is www.sana.com
      Which industry sector does Sana Biotechnology operate in?
      Sana Biotechnology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MYSZMy Size Inc
      $ 4.2001
      (211.12%)
      		121.03M
      NVNINVNI Group Ltd
      $ 8.26
      (209.36%)
      		78.06M
      TPICTPI Composites Inc
      $ 2.45
      (100.82%)
      		34M
      ICGIntchains Group Ltd
      $ 8.77
      (88.60%)
      		527.94k
      HSDTHelius Medical Technologies Inc
      $ 0.884851
      (84.34%)
      		121.95M
      CYNCYNGN Inc
      $ 0.4603
      (-71.41%)
      		27.91M
      MTEMMolecular Templates Inc
      $ 0.1502
      (-57.09%)
      		8.75M
      PRFXPainReform Ltd
      $ 5.15
      (-53.85%)
      		2.94M
      GALTGalectin Therapeutics Inc
      $ 1.03
      (-48.50%)
      		9.27M
      BCABBioAtla Inc
      $ 0.6923
      (-41.82%)
      		6.25M
      EDBLEdible Garden AG Inc
      $ 0.24
      (65.06%)
      		354.32M
      APTOAptose Biosciences Inc
      $ 0.28
      (64.51%)
      		305.1M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.606999
      (6.49%)
      		292.16M
      NVDANVIDIA Corporation
      $ 134.70
      (3.08%)
      		287.21M
      PLTRPalantir Technologies Inc
      $ 80.55
      (8.54%)
      		277.63M

      SANA Discussion

      View Posts
      Monksdream Monksdream 2 days ago
      SANA, under $2
      👍️0
      Monksdream Monksdream 2 months ago
      SANA under $5
      👍️0
      Monksdream Monksdream 4 months ago
      SANA under $7
      👍️0
      Monksdream Monksdream 5 months ago
      SANA under $7
      👍️0
      Monksdream Monksdream 6 months ago
      SANA under $10
      👍️0
      Monksdream Monksdream 10 months ago
      SANA new 52 week high
      👍️0
      Monksdream Monksdream 12 months ago
      SANA up from a low in November
      👍️0
      Moneymaker77777 Moneymaker77777 2 years ago
      https://www.globenewswire.com/news-release/2023/03/16/2629176/0/en/Sana-Biotechnology-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Business-Updates.html
      👍️0

      Your Recent History

      NASDAQ
      SANA
      Sana Biotechnology
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads